Article Details
Retrieved on: 2018-03-28 20:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>By applying advanced machine learning techniques to recent breakthroughs in genomic science, Freenome is developing noninvasive blood tests to detect early-stage cancer and make treatments more effective. The company has raised $78 million from investors such as <b>Andreessen Horowitz</b>, Google ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here